Cargando…
No More Venous Ulcers—What More Can We Do?
Venous leg ulcers (VLUs) are the most severe complication caused by the progression of chronic venous insufficiency. They account for approximately 70–90% of all chronic leg ulcers (CLUs). A total of 1% of the Western population will suffer at some time in their lives from a VLU. Furthermore, most C...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573394/ https://www.ncbi.nlm.nih.gov/pubmed/37834797 http://dx.doi.org/10.3390/jcm12196153 |
_version_ | 1785120452450975744 |
---|---|
author | Stanek, Agata Mosti, Giovanni Nematillaevich, Temirov Surat Valesky, Eva Maria Planinšek Ručigaj, Tanja Boucelma, Malika Marakomichelakis, George Liew, Aaron Fazeli, Bahar Catalano, Mariella Patel, Malay |
author_facet | Stanek, Agata Mosti, Giovanni Nematillaevich, Temirov Surat Valesky, Eva Maria Planinšek Ručigaj, Tanja Boucelma, Malika Marakomichelakis, George Liew, Aaron Fazeli, Bahar Catalano, Mariella Patel, Malay |
author_sort | Stanek, Agata |
collection | PubMed |
description | Venous leg ulcers (VLUs) are the most severe complication caused by the progression of chronic venous insufficiency. They account for approximately 70–90% of all chronic leg ulcers (CLUs). A total of 1% of the Western population will suffer at some time in their lives from a VLU. Furthermore, most CLUs are VLUs, defined as chronic leg wounds that show no tendency to heal after three months of appropriate treatment or are still not fully healed at 12 months. The essential feature of VLUs is their recurrence. VLUs also significantly impact quality of life and could cause social isolation and depression. They also have a significant avoidable economic burden. It is estimated that the treatment of venous ulceration accounts for around 3% of the total expenditure on healthcare. A VLU-free world is a highly desirable aim but could be challenging to achieve with the current knowledge of the pathophysiology and diagnostic and therapeutical protocols. To decrease the incidence of VLUs, the long-term goal must be to identify high-risk patients at an early stage of chronic venous disease and initiate appropriate preventive measures. This review discusses the epidemiology, socioeconomic burden, pathophysiology, diagnosis, modes of conservative and invasive treatment, and prevention of VLUs. |
format | Online Article Text |
id | pubmed-10573394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105733942023-10-14 No More Venous Ulcers—What More Can We Do? Stanek, Agata Mosti, Giovanni Nematillaevich, Temirov Surat Valesky, Eva Maria Planinšek Ručigaj, Tanja Boucelma, Malika Marakomichelakis, George Liew, Aaron Fazeli, Bahar Catalano, Mariella Patel, Malay J Clin Med Review Venous leg ulcers (VLUs) are the most severe complication caused by the progression of chronic venous insufficiency. They account for approximately 70–90% of all chronic leg ulcers (CLUs). A total of 1% of the Western population will suffer at some time in their lives from a VLU. Furthermore, most CLUs are VLUs, defined as chronic leg wounds that show no tendency to heal after three months of appropriate treatment or are still not fully healed at 12 months. The essential feature of VLUs is their recurrence. VLUs also significantly impact quality of life and could cause social isolation and depression. They also have a significant avoidable economic burden. It is estimated that the treatment of venous ulceration accounts for around 3% of the total expenditure on healthcare. A VLU-free world is a highly desirable aim but could be challenging to achieve with the current knowledge of the pathophysiology and diagnostic and therapeutical protocols. To decrease the incidence of VLUs, the long-term goal must be to identify high-risk patients at an early stage of chronic venous disease and initiate appropriate preventive measures. This review discusses the epidemiology, socioeconomic burden, pathophysiology, diagnosis, modes of conservative and invasive treatment, and prevention of VLUs. MDPI 2023-09-23 /pmc/articles/PMC10573394/ /pubmed/37834797 http://dx.doi.org/10.3390/jcm12196153 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Stanek, Agata Mosti, Giovanni Nematillaevich, Temirov Surat Valesky, Eva Maria Planinšek Ručigaj, Tanja Boucelma, Malika Marakomichelakis, George Liew, Aaron Fazeli, Bahar Catalano, Mariella Patel, Malay No More Venous Ulcers—What More Can We Do? |
title | No More Venous Ulcers—What More Can We Do? |
title_full | No More Venous Ulcers—What More Can We Do? |
title_fullStr | No More Venous Ulcers—What More Can We Do? |
title_full_unstemmed | No More Venous Ulcers—What More Can We Do? |
title_short | No More Venous Ulcers—What More Can We Do? |
title_sort | no more venous ulcers—what more can we do? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573394/ https://www.ncbi.nlm.nih.gov/pubmed/37834797 http://dx.doi.org/10.3390/jcm12196153 |
work_keys_str_mv | AT stanekagata nomorevenousulcerswhatmorecanwedo AT mostigiovanni nomorevenousulcerswhatmorecanwedo AT nematillaevichtemirovsurat nomorevenousulcerswhatmorecanwedo AT valeskyevamaria nomorevenousulcerswhatmorecanwedo AT planinsekrucigajtanja nomorevenousulcerswhatmorecanwedo AT boucelmamalika nomorevenousulcerswhatmorecanwedo AT marakomichelakisgeorge nomorevenousulcerswhatmorecanwedo AT liewaaron nomorevenousulcerswhatmorecanwedo AT fazelibahar nomorevenousulcerswhatmorecanwedo AT catalanomariella nomorevenousulcerswhatmorecanwedo AT patelmalay nomorevenousulcerswhatmorecanwedo |